
|Articles|January 1, 2003
Tough Stuff
Author(s)Andrew Bowser
New York - For severe forms of psoriasis, dermatologists should choose treatments based on efficacy and rapidity of response more so than potential for chronic toxicities, according to Kenneth B. Gordon, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Transformative Advances This Year and Beyond
5


















